Hendrik Wolf

1.1k total citations
30 papers, 744 citations indexed

About

Hendrik Wolf is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Hendrik Wolf has authored 30 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology and Allergy, 16 papers in Physiology and 14 papers in Dermatology. Recurrent topics in Hendrik Wolf's work include Allergic Rhinitis and Sensitization (25 papers), Asthma and respiratory diseases (15 papers) and Dermatology and Skin Diseases (14 papers). Hendrik Wolf is often cited by papers focused on Allergic Rhinitis and Sensitization (25 papers), Asthma and respiratory diseases (15 papers) and Dermatology and Skin Diseases (14 papers). Hendrik Wolf collaborates with scholars based in Germany, Denmark and Austria. Hendrik Wolf's co-authors include J Schnitker, Jörg Schnitker, Randolf Brehler, Bernhard Przybilla, Franziska Ruëff, Alexander Kapp, M. Grewe, Margitta Worm, Kristine Breuer and T. Ruzicka and has published in prestigious journals such as Radiology, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Hendrik Wolf

26 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hendrik Wolf Germany	14	577	372	351	113	78	30	744
E. Rijntjes Netherlands	19	662 1.1×	131 0.4×	639 1.8×	268 2.4×	123 1.6×	28	983
Steeve Genestet France	7	45 0.1×	133 0.4×	195 0.6×	5 0.0×	99 1.3×	17	372
Hornstein Op Germany	9	37 0.1×	127 0.3×	66 0.2×	16 0.1×	47 0.6×	87	388
Saltanat Ualiyeva United States	6	53 0.1×	49 0.1×	143 0.4×	52 0.5×	79 1.0×	12	369
Mushtaq Ali United States	7	90 0.2×	9 0.0×	138 0.4×	80 0.7×	45 0.6×	9	382
Stefano Settimi Italy	13	153 0.3×	10 0.0×	156 0.4×	75 0.7×	120 1.5×	40	393
Selahattin Tuğrul Türkiye	12	19 0.0×	38 0.1×	106 0.3×	79 0.7×	225 2.9×	58	401
Iuliana Badiu Italy	11	133 0.2×	34 0.1×	223 0.6×	142 1.3×	27 0.3×	23	349
Bülent Mamıkoğlu United States	13	112 0.2×	22 0.1×	162 0.5×	23 0.2×	216 2.8×	25	608
Pedro Benítez Spain	12	214 0.4×	4 0.0×	153 0.4×	55 0.5×	175 2.2×	19	553

Countries citing papers authored by Hendrik Wolf

Since Specialization

Citations

This map shows the geographic impact of Hendrik Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Wolf more than expected).

Fields of papers citing papers by Hendrik Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Wolf. The network helps show where Hendrik Wolf may publish in the future.

Co-authorship network of co-authors of Hendrik Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Wolf. A scholar is included among the top collaborators of Hendrik Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Wolf. Hendrik Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfaar, Oliver, Hendrik Wolf, André C. Knulst, et al.. (2024). Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real‐life. Clinical and Translational Allergy. 14(7). e12373–e12373. 2 indexed citations

Langenbruch, Anna, Eike Wüstenberg, Hendrik Wolf, & Matthias Augustin. (2022). Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy. Journal of Asthma and Allergy. Volume 15. 611–621. 1 indexed citations

Wolf, Hendrik, et al.. (2021). Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study. The Journal of Allergy and Clinical Immunology In Practice. 9(8). 3221–3223.e5. 5 indexed citations

Horn, Andreas, et al.. (2020). Shortened Up-Dosing With 7 Injections of Subcutaneous Allergy Immunotherapy (Alutard SQ) Is Safe and Well Tolerated. Journal of Investigational Allergology and Clinical Immunology. 31(1). 80–83. 3 indexed citations

Wolf, Hendrik, et al.. (2018). Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study. Pulmonary Therapy. 4(1). 45–57. 1 indexed citations

Wolf, Hendrik, et al.. (2017). Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study. Drugs - Real World Outcomes. 4(1). 65–74.

Langenbruch, Anna, et al.. (2017). Patientenseitige Ziele und Erwartungen an die Behandlung der allergischen Rhinokonjunktivitis mit Allergie-Immuntherapie. Allergologie. 40(4). 135–143. 2 indexed citations

Horn, Andreas, et al.. (2016). Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study. Clinical Drug Investigation. 36(6). 453–462. 16 indexed citations

Wolf, Hendrik, et al.. (2015). Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study. Clinical and Translational Allergy. 6(1). 9–9. 4 indexed citations

10.

Pfaar, Oliver, Hendrik Wolf, Ludger Klimek, Jörg Schnitker, & Eike Wüstenberg. (2012). Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A Double-Blind, Randomized, Placebo-Controlled Trial. Clinical Therapeutics. 34(10). 2072–2081. 16 indexed citations

11.

Bergmann, Karl‐Christian, Hendrik Wolf, & Jörg Schnitker. (2008). Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome. World Allergy Organization Journal. 1(5). 79–84. 16 indexed citations

12.

Werfel, Thomas, Kristine Breuer, Franziska Ruëff, et al.. (2006). Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study. Allergy. 61(2). 202–205. 176 indexed citations

13.

Rolinck‐Werninghaus, Claudia, Hendrik Wolf, Joep M. A. Lange, et al.. (2004). A prospective, randomized, double‐blind, placebo‐controlled multi‐centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy. 59(12). 1285–1293. 94 indexed citations

14.

Ruëff, Franziska, Hendrik Wolf, J Schnitker, Johannes Ring, & Bernhard Przybilla. (2004). Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy. 59(6). 589–595. 46 indexed citations

15.

Brehler, Randolf, Hendrik Wolf, Birgitta Kütting, Jörg Schnitker, & Thomas J. Luger. (2000). Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. Journal of Allergy and Clinical Immunology. 105(6). 1231–1235. 74 indexed citations

16.

Klimek, Ludger, Hendrik Wolf, Dirk Dormann, et al.. (1999). The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. Journal of Allergy and Clinical Immunology. 103(1). 47–53. 40 indexed citations

17.

Balda, B.-R., Hendrik Wolf, C. Baumgarten, et al.. (1998). Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy. 53(8). 740–748. 36 indexed citations

18.

Przuntek, H., D. Welzel, W Danielczyk, et al.. (1992). Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued. European Journal of Clinical Pharmacology. 43(4). 357–363. 49 indexed citations

19.

Strecker, E. P., Dieter Liermann, Klemens H. Barth, et al.. (1990). Expandable tubular stents for treatment of arterial occlusive diseases: experimental and clinical results. Work in progress.. Radiology. 175(1). 97–102. 82 indexed citations

20.

Büchler, Markus, Peter Malfertheiner, Waldemar Uhl, et al.. (1988). [Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)].. PubMed. 83(10). 320–4, 352. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact